Stock market futures are pointing lower as geopolitical risks in the Middle East have intensified. With tensions escalating between Israel and Iran, oil prices have climbed along with safe-haven assets, prompting traders into Treasuries and gold. However, despite the conflict, equities demonstrated resilience: stock futures have rebounded slightly, helped by the retreat in oil after its initial spike and the strength in long-term government debt imports .
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Market participants are focused on the Federal Reserve meeting kicking off today as well. Rates are widely expected to remain unchanged, but the tone toward future cuts remains open as inflation cools and Treasury demand strengthens
In pre-market trading, S&P 500 futures fell 0.37%, Nasdaq futures fell 0.38% and Dow futures fell 0.42%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
Also, The Fly has brought its right-to-the-point stock market reporting to YouTube! Subscribe if you want to know how the markets will open and what stocks traders will be focused on.
HIGHER –
- Verve Therapeutics (VERV) up 76% after announcing deal for Eli Lilly (LLY) to acquire all of the outstanding shares of the company for a purchase price of $10.50 per share in cash, plus one non-tradeable contingent value right per share that entitles the holder to receive up to an additional $3.00 per share
- Immuneering (IMRX) up 4% after announcing data from its ongoing Phase 2a clinical trial evaluating atebimetinib in combination with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer patients
UP AFTER EARNINGS –
LOWER –
- Dyne Therapeutics (DYN) down 18% after revising the endpoint of its DYNE-101 trial
- LeddarTech (LDTC) down 17% after announcing that it intends on making an assignment into bankruptcy pursuant to the Bankruptcy and Insolvency Act
- Redwire (RDW) down 17% after pricing 15.5M share offering at $16.75
- Eli Lilly (LLY) down 1% after deal to acquire Verve
- Westlake (WLK) down 1% after announcing an additional workforce reduction of approximately 230 employees
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERV:
- Video: Verve, solar stocks among major pre-market movers
- Verve Therapeutics Merges with Eli Lilly in Acquisition
- Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash
- M&A News: Verve Therapeutics Stock (VERV) Rallies 75% on News of Potential Acquisition by Eli Lilly
- Verve Therapeutics Holds Annual Stockholders Meeting